Skip to main content
. Author manuscript; available in PMC: 2018 Jan 28.
Published in final edited form as: AIDS. 2017 Jan 28;31(3):355–364. doi: 10.1097/QAD.0000000000001312

Figure 1.

Figure 1

Percentage of children with plasma HIV-RNA 50–1000 copies/mL (cpm) and VL ≥1000 cpm at scheduled trial visits in Cohort C.2 and Cohort D by age at antiretroviral therapy (ART) initiation (<6 months vs. 6–24 months)